Stay updated on Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page.

Latest updates to the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page
- Check8 days agoChange DetectedRevision: v3.6.3 has been added and the previous Revision: v3.6.2 has been removed. This appears to be a minor update to the page's metadata indicating a small internal change.SummaryDifference0.0%

- Check15 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, indicating a minor update to the page’s documentation or backend. No user-facing content changes are introduced by this update.SummaryDifference0.0%

- Check30 days agoChange DetectedRecruitment status shows no longer looking for participants, indicating accrual is closed. The page also introduces help sections (How to Read a Study Record, Common Questions, How to Join a Study) and changes the Intervention/Treatment heading formatting, with a revision update to v3.6.0.SummaryDifference0.3%

- Check37 days agoChange DetectedThe page revision label changed from v3.5.4 to v3.5.5. This signals a minor update to the page's version metadata.SummaryDifference0.0%

- Check51 days agoChange DetectedThe revision tag on the page updated from v3.5.3 to v3.5.4, indicating an updated build of the document or interface assets.SummaryDifference0.0%

- Check73 days agoChange DetectedRevision label updated to v3.5.3, indicating a newer version of the page. This reflects a minor update to the page’s versioning rather than a substantive change to study details.SummaryDifference0.0%

Stay in the know with updates to Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page.